BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
2 hedge funds and large institutions have $26K invested in BioDelivery Sciences International, Inc. in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 152 closing their positions.
1,033% more call options, than puts
Call options by funds: $34K | Put options by funds: $3K
99% less funds holding
Funds holding: 156 → 2 (-154)
100% less capital invested
Capital invested by funds: $181M → $26K (-$181M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 152
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$22.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.7M |
| 3 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$13.5M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$10.9M |
| 5 |
RA
Royce & Associates
New York
|
-$7.46M |
BDSI Hedge Fund Activity: Q1 2022 in Review
2 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2022, worth a combined $26K — down 100% from $181M a quarter earlier.
Sellers outnumbered buyers: 152 funds closed out of BDSI and 0 opened new positions — a net loss of 152 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $22.6M sold.
- 2 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2022, down from 156 in Q4 2021.
- Funds reported $26K of BioDelivery Sciences International, Inc. stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2022 and 152 closed out, a net change of -152 holders.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2022 was BlackRock, an estimated $22.6M sold.
Based on aggregated 13F filings for Q1 2022.